Cefixime is a third-generation cephalosporin antibiotic that is widely used in the treatment of various bacterial infections. It is particularly effective against a broad spectrum of gram-positive and gram-negative bacteria, making it a versatile choice for healthcare providers.

This API works by inhibiting bacterial cell wall synthesis, which ultimately leads to the death of the bacteria. Cefixime is often prescribed for conditions such as otitis media, pharyngitis, tonsillitis, and urinary tract infections, among others.

Its oral bioavailability and convenient dosing schedule make it a preferred option for outpatient therapy. Cefixime is generally well-tolerated, with a safety profile that is favorable for both adults and children.

Common side effects may include gastrointestinal disturbances, such as diarrhea and nausea, but these are typically mild and transient. As with all antibiotics, it is crucial to complete the full course of therapy to prevent the development of resistant bacterial strains.

Prescribers should be aware of potential drug interactions and contraindications, particularly in patients with a history of hypersensitivity to cephalosporins or penicillins. Monitoring renal function may be necessary in patients with renal impairment, as dosage adjustments could be required.

Overall, Cefixime remains a reliable and effective choice for treating a variety of bacterial infections, and its inclusion in compounded formulations allows for tailored dosing and administration to meet specific patient needs.